National Health Investors (NHI)
(Delayed Data from NYSE)
$62.83 USD
+1.01 (1.63%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $62.13 -0.70 (-1.11%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
NHI 62.83 +1.01(1.63%)
Will NHI be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for NHI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NHI
National Health Investors (NHI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
National Health Investors (NHI) Q4 FFO Top Estimates
NHI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Four Corners Property Trust (FCPT) Q4 FFO Surpass Estimates
National Health Investors (NHI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Extra Space Storage (EXR) Surges 3.5%: Is This an Indication of Further Gains?
Other News for NHI
Worried About Stocks? Why Not Lock In 6% And Call It A Day? Or Decade?
NHI Breaks Above 6% Yield Territory
BMO upgrades National Health Investors to Outperform
Beyond The Numbers: 4 Analysts Discuss National Health Investors Stock
Optimistic Buy Rating for National Health Investors on Strong SHOP Performance and Strategic Acquisitions